Adaptive Phage Therapeutics
ID: 6953780Adaptive Phage Therapeutics is a phage treatments targeting multi-drug resistant bacteria founded in 2016 by Greg Merril.
7
Funding Rounds
$104.4m
Money raised
Recent Funding Rounds
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| Ca** Me**** | - | - | - |
| Gr** Me**** |
|
- |
Funding series
Funding Series Analysis
The company Adaptive Phage Therapeutics has raised a total of $20m in funding over 7 rounds.
Key Insights:
- Adaptive Phage Therapeutics , April 2022: $20m
- Adaptive Phage Therapeutics Convertible note, June 2020: $6.2m
- Adaptive Phage Therapeutics Seed round, February 2017: $765k
- Adaptive Phage Therapeutics Grant (money), January 2020: $10.2m
- Adaptive Phage Therapeutics Debt Financing, January 2018: $7m
- Adaptive Phage Therapeutics Venture round, October 2019: $7m
- Adaptive Phage Therapeutics, Inc. funding round, May 2021: $53.26m
Industries
Adaptive Phage Therapeutics is active in the following industries: